Giselle Mosnaim to Anaphylaxis
This is a "connection" page, showing publications Giselle Mosnaim has written about Anaphylaxis.
Connection Strength
0.187
-
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. J Allergy Clin Immunol Pract. 2021 10; 9(10):3546-3567.
Score: 0.187